Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of three artemisinin-based combination therapies for uncomplicated falciparum malaria in central Vietnam
ACTRN12609000816257Phase 3Completed
- Sponsor
- Australian Defence Force Malaria and Infectious Disease Institute
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of Artequick, artesunate + amodiaquine, artesunate and azithromycin in Malaria (3 arms), sponsored by Australian Defence Force Malaria and Infectious Disease Institute. Primary endpoint: Therapeutic efficacy and tolerability. Started May 2008; status: completed.
02
Drugs
Artequickartesunate + amodiaquineartesunateazithromycin
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12609000816257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000816257.